Partner Therapeutics focuses on developing and commercializing approved and late-stage therapies that enhance treatment outcomes and reduce the cost of cancer care. Their drug development covers various stages of cancer therapy, from primary treatments to supportive care. The company is committed to making a meaningful difference in the lives of cancer patients by providing cancer medicines and combination therapies. They prioritize patient needs and strive to support them throughout their treatment journey. Partner Therapeutics believes in a collaborative approach to fighting cancer, working with experts, leading companies, investigators, and patient advocacy organizations. They aim to maximize the benefits to patients and advance the understanding of cancer treatment. The company's success is measured by the real-world impact their products have on improving the quality and duration of patients' lives.